Business · 17/08/2016Updated: 10/17/2026 · 1 min read
FDA Announces Guidance on Using Nucleic Acid Tests to Reduce Hepatitis B Transmission Risk
Summary
The Food and Drug Administration (FDA) has released a guidance document outlining the use of nucleic acid tests to minimize the risk of hepatitis B virus transmission from human cell, tissue, and product donors, finalizing a draft from 2016 and supplementing previous recommendations from 2007.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →